Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News


February 13, 2013
Will combine immune therapy with Albufuse technology  Read More »

February 13, 2013
Manufactures material for Phase II PLIANT trial  Read More »

February 13, 2013
Aims to improve manufacturing routes for selected APIs  Read More »

February 13, 2013
Specialty Injectable sales up 12% in the quarter  Read More »

February 13, 2013
Aims to advance EDC in clinical trials  Read More »

February 13, 2013
Anderson brings 28 years of inhalation expertise  Read More »

February 12, 2013
Aims to discover, commercialize small-molecule therapies  Read More »

February 12, 2013
Lemke brings more than 20 years of experience  Read More »

February 12, 2013
Unaudited revenues up 44% in the quarter  Read More »

February 12, 2013
Applications range from drug delivery to physiological sensing  Read More »

February 12, 2013
BMS to market several OTC medicines in Latin America  Read More »
Gil Roth
February 11, 2013
Chai to take over tubulin compound  Read More »
Gil Roth
February 11, 2013
Rehse to lead Structural Biology  Read More »

February 11, 2013
Will manufacture and supply DEFINITY, Cardiolite and Neurolite  Read More »

February 11, 2013
Expands liquid categories and Rx medicines, broadens market access  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On